• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CNS 糖基磷脂酰肌醇缺乏导致新型小鼠模型中白质发育迟缓、共济失调和早亡。

CNS glycosylphosphatidylinositol deficiency results in delayed white matter development, ataxia and premature death in a novel mouse model.

机构信息

Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.

Medical Scientist Training Program, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.

出版信息

Hum Mol Genet. 2020 May 8;29(7):1205-1217. doi: 10.1093/hmg/ddaa046.

DOI:10.1093/hmg/ddaa046
PMID:32179897
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7206848/
Abstract

The glycosylphosphatidylinositol (GPI) anchor is a post-translational modification added to approximately 150 different proteins to facilitate proper membrane anchoring and trafficking to lipid rafts. Biosynthesis and remodeling of the GPI anchor requires the activity of over 20 distinct genes. Defects in the biosynthesis of GPI anchors in humans lead to inherited glycosylphosphatidylinositol deficiency (IGD). IGD patients display a wide range of phenotypes though the central nervous system (CNS) appears to be the most commonly affected tissue. A full understanding of the etiology of these phenotypes has been hampered by the lack of animal models due to embryonic lethality of GPI biosynthesis gene null mutants. Here we model IGD by genetically ablating GPI production in the CNS with a conditional mouse allele of phosphatidylinositol glycan anchor biosynthesis, class A (Piga) and Nestin-Cre. We find that the mutants do not have structural brain defects but do not survive past weaning. The mutants show progressive decline with severe ataxia consistent with defects in cerebellar development. We show that the mutants have reduced myelination and defective Purkinje cell development. Surprisingly, we found that Piga was expressed in a fairly restricted pattern in the early postnatal brain consistent with the defects we observed in our model. Thus, we have generated a novel mouse model of the neurological defects of IGD which demonstrates a critical role for GPI biosynthesis in cerebellar and white matter development.

摘要

糖基磷脂酰肌醇(GPI)锚定是一种翻译后修饰,可添加到大约 150 种不同的蛋白质上,以促进适当的膜锚定和向脂筏的运输。GPI 锚定的生物合成和重塑需要 20 多种不同基因的活性。人类 GPI 锚定生物合成缺陷会导致遗传性糖基磷脂酰肌醇缺乏症(IGD)。尽管中枢神经系统(CNS)似乎是最常受影响的组织,但 IGD 患者表现出广泛的表型。由于 GPI 生物合成基因缺失突变体的胚胎致死性,缺乏动物模型一直阻碍着对这些表型病因的全面理解。在这里,我们通过使用条件性小鼠磷酸肌醇聚糖锚生物合成 A 类(Piga)和巢蛋白-Cre 基因敲除来遗传消除 CNS 中的 GPI 产生,从而模拟 IGD。我们发现突变体没有结构脑缺陷,但在断奶后不能存活。突变体表现出进行性下降,伴有严重的共济失调,与小脑发育缺陷一致。我们发现突变体的髓鞘形成减少,浦肯野细胞发育缺陷。令人惊讶的是,我们发现 Piga 在出生后早期的大脑中以相当受限的模式表达,与我们在模型中观察到的缺陷一致。因此,我们已经生成了一种新的 IGD 神经缺陷的小鼠模型,该模型证明了 GPI 生物合成在小脑和白质发育中的关键作用。

相似文献

1
CNS glycosylphosphatidylinositol deficiency results in delayed white matter development, ataxia and premature death in a novel mouse model.CNS 糖基磷脂酰肌醇缺乏导致新型小鼠模型中白质发育迟缓、共济失调和早亡。
Hum Mol Genet. 2020 May 8;29(7):1205-1217. doi: 10.1093/hmg/ddaa046.
2
Reduced cell surface levels of GPI-linked markers in a new case with PIGG loss of function.新型 PIGG 功能丧失病例中糖基磷脂酰肌醇(GPI)连接标记物的细胞表面水平降低。
Hum Mutat. 2017 Oct;38(10):1394-1401. doi: 10.1002/humu.23268. Epub 2017 Jun 12.
3
Limb-clasping, cognitive deficit and increased vulnerability to kainic acid-induced seizures in neuronal glycosylphosphatidylinositol deficiency mouse models.神经元糖基磷脂酰肌醇缺乏症小鼠模型的肢体紧抱、认知缺陷和对红藻氨酸诱导的癫痫易感性增加。
Hum Mol Genet. 2021 May 28;30(9):758-770. doi: 10.1093/hmg/ddab052.
4
Mutations in PIGB Cause an Inherited GPI Biosynthesis Defect with an Axonal Neuropathy and Metabolic Abnormality in Severe Cases.PIGB 基因突变导致严重病例的遗传性 GPI 生物合成缺陷伴轴索神经病和代谢异常。
Am J Hum Genet. 2019 Aug 1;105(2):384-394. doi: 10.1016/j.ajhg.2019.05.019. Epub 2019 Jun 27.
5
PIGQ-Related Glycophosphatidylinositol Deficiency Associated with Nonprogressive Congenital Ataxia.PIGQ 相关糖基磷脂酰肌醇缺陷与进行性先天性共济失调。
Cerebellum. 2022 Aug;21(4):525-530. doi: 10.1007/s12311-021-01288-x. Epub 2021 Jun 5.
6
Clinical variability in inherited glycosylphosphatidylinositol deficiency disorders.遗传性糖基磷脂酰肌醇缺陷疾病的临床变异性。
Clin Genet. 2019 Jan;95(1):112-121. doi: 10.1111/cge.13425. Epub 2018 Aug 16.
7
A likely pathogenic variant putatively affecting splicing of PIGA identified in a multiple congenital anomalies hypotonia-seizures syndrome 2 (MCAHS2) family pedigree via whole-exome sequencing.通过全外显子组测序,在一个患有多种先天性异常、肌张力减退 - 癫痫综合征2(MCAHS2)的家系谱系中鉴定出一个可能影响PIGA剪接的潜在致病变异。
Mol Genet Genomic Med. 2018 Sep;6(5):739-748. doi: 10.1002/mgg3.428. Epub 2018 Jul 4.
8
Inherited glycosylphosphatidylinositol defects cause the rare Emm-negative blood phenotype and developmental disorders.遗传性糖基磷脂酰肌醇缺陷导致罕见的 Emm 阴性血液表型和发育障碍。
Blood. 2021 Jul 1;137(26):3660-3669. doi: 10.1182/blood.2020009810.
9
Congenital disorder of glycosylphosphatidylinositol (GPI)-anchor biosynthesis--The phenotype of two patients with novel mutations in the PIGN and PGAP2 genes.糖基磷脂酰肌醇(GPI)锚生物合成先天性疾病——两名PIGN和PGAP2基因存在新突变患者的表型
Eur J Paediatr Neurol. 2016 May;20(3):462-73. doi: 10.1016/j.ejpn.2016.01.007. Epub 2016 Feb 4.
10
Significantly different clinical phenotypes associated with mutations in synthesis and transamidase+remodeling glycosylphosphatidylinositol (GPI)-anchor biosynthesis genes.与合成和转酰胺+重塑糖基磷脂酰肌醇(GPI)锚生物合成基因中的突变相关的显著不同的临床表型。
Orphanet J Rare Dis. 2020 Feb 4;15(1):40. doi: 10.1186/s13023-020-1313-0.

引用本文的文献

1
Identification of CNTN2 as a genetic modifier of PIGA-CDG in a family with incomplete penetrance and in Drosophila.在一个具有不完全外显率的家族以及果蝇中鉴定出CNTN2作为PIGA-CDG的遗传修饰因子。
Am J Hum Genet. 2025 Mar 6;112(3):572-582. doi: 10.1016/j.ajhg.2025.01.017. Epub 2025 Feb 12.
2
PIGK defects induce apoptosis in Purkinje cells and acceleration of neuroectodermal differentiation.PIGK 缺陷诱导浦肯野细胞凋亡和神经外胚层分化加速。
Cell Death Dis. 2024 Nov 9;15(11):808. doi: 10.1038/s41419-024-07201-8.
3
Promise of gene therapy for congenital neurologic disease due to GPI deficiency.针对因糖基磷脂酰肌醇(GPI)缺乏所致先天性神经疾病的基因治疗前景。
Mol Ther Methods Clin Dev. 2024 Mar 25;32(2):101240. doi: 10.1016/j.omtm.2024.101240. eCollection 2024 Jun 13.
4
The clinical and genetic spectrum of inherited glycosylphosphatidylinositol deficiency disorders.遗传性糖基磷脂酰肌醇缺乏症的临床和遗传谱系。
Brain. 2024 Aug 1;147(8):2775-2790. doi: 10.1093/brain/awae056.
5
AAV-based gene therapy ameliorated CNS-specific GPI defect in mouse models.基于腺相关病毒的基因疗法改善了小鼠模型中中枢神经系统特异性糖基磷脂酰肌醇缺陷。
Mol Ther Methods Clin Dev. 2023 Dec 14;32(1):101176. doi: 10.1016/j.omtm.2023.101176. eCollection 2024 Mar 14.
6
Drosophila models of phosphatidylinositol glycan biosynthesis class A congenital disorder of glycosylation (PIGA-CDG) mirror patient phenotypes.果蝇模型的磷脂酰肌醇聚糖生物合成 A 类先天性糖基化障碍 (PIGA-CDG) 反映了患者表型。
G3 (Bethesda). 2024 Mar 6;14(3). doi: 10.1093/g3journal/jkad291.
7
A Novel Homozygous Variant in a Patient with a Glycosylphosphatidylinositol Biosynthesis Defect.一个糖基磷脂酰肌醇生物合成缺陷患者中的新型纯合变异。
Genes (Basel). 2023 Jul 14;14(7):1444. doi: 10.3390/genes14071444.
8
The Regulatory Roles of Cerebellar Glycosphingolipid Microdomains/Lipid Rafts.小脑糖鞘脂微域/脂筏的调节作用。
Int J Mol Sci. 2023 Mar 14;24(6):5566. doi: 10.3390/ijms24065566.
9
Case report: Functional characterization of a c.145G>A p.Val49Met pathogenic variant in a case of PIGA-CDG with megacolon.病例报告:一例患有巨结肠的PIGA-CDG病例中c.145G>A p.Val49Met致病变异的功能特征分析
Front Genet. 2022 Oct 17;13:971473. doi: 10.3389/fgene.2022.971473. eCollection 2022.
10
Genomic, transcriptomic, and metabolomic profiles of hiPSC-derived dopamine neurons from clinically discordant brothers with identical PRKN deletions.来自具有相同PRKN缺失的临床症状不一致的兄弟的人诱导多能干细胞衍生多巴胺神经元的基因组、转录组和代谢组图谱。
NPJ Parkinsons Dis. 2022 Jun 29;8(1):84. doi: 10.1038/s41531-022-00346-3.

本文引用的文献

1
Glycosylphosphatidylinositol biosynthesis and remodeling are required for neural tube closure, heart development, and cranial neural crest cell survival.糖基磷脂酰肌醇的生物合成和重塑对于神经管闭合、心脏发育和颅神经嵴细胞存活是必需的。
Elife. 2019 Jun 24;8:e45248. doi: 10.7554/eLife.45248.
2
Modeling Congenital Disorders of N-Linked Glycoprotein Glycosylation in .在……中模拟N-连接糖蛋白糖基化的先天性疾病
Front Genet. 2018 Oct 2;9:436. doi: 10.3389/fgene.2018.00436. eCollection 2018.
3
Mutations in PIGS, Encoding a GPI Transamidase, Cause a Neurological Syndrome Ranging from Fetal Akinesia to Epileptic Encephalopathy.编码 GPI 转酰胺酶的 PIGS 基因突变导致从胎儿运动不能到癫痫性脑病的神经综合征。
Am J Hum Genet. 2018 Oct 4;103(4):602-611. doi: 10.1016/j.ajhg.2018.08.014. Epub 2018 Sep 27.
4
Clinical variability in inherited glycosylphosphatidylinositol deficiency disorders.遗传性糖基磷脂酰肌醇缺陷疾病的临床变异性。
Clin Genet. 2019 Jan;95(1):112-121. doi: 10.1111/cge.13425. Epub 2018 Aug 16.
5
Characterization of glycosylphosphatidylinositol biosynthesis defects by clinical features, flow cytometry, and automated image analysis.通过临床特征、流式细胞术和自动化图像分析来描述糖基磷脂酰肌醇生物合成缺陷。
Genome Med. 2018 Jan 9;10(1):3. doi: 10.1186/s13073-017-0510-5.
6
Neural Glycosylphosphatidylinositol-Anchored Proteins in Synaptic Specification.神经糖基磷脂酰肌醇锚定蛋白在突触特化中的作用。
Trends Cell Biol. 2017 Dec;27(12):931-945. doi: 10.1016/j.tcb.2017.06.007. Epub 2017 Jul 22.
7
[Molecular genetics, biochemistry, and biology of PNH].[阵发性睡眠性血红蛋白尿的分子遗传学、生物化学及生物学]
Rinsho Ketsueki. 2017;58(4):353-362. doi: 10.11406/rinketsu.58.353.
8
A hypomorphic PIGA gene mutation causes severe defects in neuron development and susceptibility to complement-mediated toxicity in a human iPSC model.一个低表达的PIGA基因突变在人诱导多能干细胞模型中导致神经元发育的严重缺陷以及对补体介导毒性的易感性。
PLoS One. 2017 Apr 25;12(4):e0174074. doi: 10.1371/journal.pone.0174074. eCollection 2017.
9
Analysis of exome data for 4293 trios suggests GPI-anchor biogenesis defects are a rare cause of developmental disorders.对4293个三联体的外显子组数据进行分析表明,糖基磷脂酰肌醇(GPI)锚生物合成缺陷是发育障碍的罕见病因。
Eur J Hum Genet. 2017 Jun;25(6):669-679. doi: 10.1038/ejhg.2017.32. Epub 2017 Mar 22.
10
A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy.脑瘫新生小鼠模型中的一组运动测试
J Vis Exp. 2016 Nov 3(117):53569. doi: 10.3791/53569.